Pfizer Bio-N-Tech vaccination
The European Medicines Agency is likely to approve a Covid-19 vaccine for use in children aged 12-15, later today.
The use of the Pfizer Bio-N-Tech inoculation is being reviewed by the Europeans Medicines Agency.
Similar approval was granted in the US earlier this month.

Approximately 900 Irish Citizens Stuck In Transit In The Middle East
US Supreme Court Rules Against President Trump's Global Tariffs